Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.5K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

619
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
619
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Next-generation Sequencing03:00

Next-generation Sequencing

95.4K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
95.4K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.9K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K
Sanger Sequencing01:57

Sanger Sequencing

765.1K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
765.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PARP1 as a biomarker for differentiating melanoma from benign melanocytic lesions.

The Journal of investigative dermatology·2026
Same author

Recurrent right atrial myxoma presenting as pulmonary hypertension and peripheral pulmonary artery aneurysms.

Thorax·2025
Same author

The 11th Annual Northeastern Evolutionary Primatologists (NEEP) Meeting.

Evolutionary anthropology·2025
Same author

Today's Research, Tomorrow's Practice - White Paper from the Translation of New Therapy (TNT) Radiotheranostics Kick-off Pre-meeting of the Annual World Molecular Imaging Conference 2024.

Molecular imaging and biology·2025
Same author

Enabling high-resolution diagnostic oral confocal laser endomicroscopy in mice.

Methods (San Diego, Calif.)·2025
Same author

Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting.

BMC medicine·2025

Related Experiment Video

Updated: Nov 9, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.1K

Auger: The future of precision medicine.

Giacomo Pirovano1, Thomas C Wilson1, Thomas Reiner2

  • 1Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

Nuclear Medicine and Biology
|April 8, 2021
PubMed
Summary

The Auger effect uses low-energy electron emission for targeted radiotherapy. This method delivers precise radiation to cancer cells using targeting vectors, minimizing harm to healthy tissues.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.6K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.2K

Related Experiment Videos

Last Updated: Nov 9, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

12.1K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.6K
Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
07:03

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

1.2K

Area of Science:

  • Nuclear Physics
  • Radiochemistry
  • Medical Physics

Background:

  • The Auger effect involves low-energy electron emission after atomic excitation.
  • This phenomenon creates localized, high-energy deposition ideal for targeted therapies.
  • Targeted radiotherapy aims to deliver radiation precisely to diseased cells, sparing healthy ones.

Purpose of the Study:

  • To review recent preclinical and clinical studies on Auger emitters in targeted radiotherapy.
  • To highlight the use of small molecules, peptides, and antibodies as targeting vectors.
  • To discuss how these studies can inform future research and clinical applications.

Main Methods:

  • Review of existing literature on Auger effect applications in radiotherapy.
  • Analysis of preclinical and clinical studies utilizing Auger emitters with targeting vectors.
  • Focus on studies employing small molecules, peptides, and antibodies for targeted delivery.

Main Results:

  • Auger emitters offer highly localized radiation with high linear energy transfer (LET).
  • Targeting vectors enable precise delivery to tumor biomarkers, reducing off-site toxicity.
  • Promising preclinical and clinical results demonstrate the potential of this approach.

Conclusions:

  • Auger emitters are promising for targeted radiotherapy due to their short-range, high-LET emissions.
  • Targeting vectors like small molecules, peptides, and antibodies enhance precision and safety.
  • Successful preclinical and clinical studies provide a foundation for future Auger therapy development.